Find Demand.
We research active demand across multiple health conditions and find a B2C SaaS opportunity exists for B2B telemedicine platform Zipnosis.
Measure the Competition.
Our research reveals a weak, compromised competitive set leaving open multiple opportunities for Zipnosis to win in B2C.
Imagine the Experience.
Our recommendation: target consumers when and where they seek information to self-diagnose, build a strong visual brand to stand out from competitive clutter, deliver a frictionless customer intake experience, and adopt an easy-to-engage consumer-pricing model.
Pilot. Test. Iterate. Grow.
Infallible proposes a market test targeting four states with the greatest demand for Skin Health.
Results.
The plan is approved by the Zipnosis board. One week later, COVID-19 begins and their B2B telemedicine business is overrun with demand from health systems. Zipnosis grows with the pandemic and is acquired in 2021. The B2C plan is never executed.
Find Demand.
We research active demand across multiple health conditions and find a B2C SaaS opportunity exists for B2B telemedicine platform Zipnosis.
Measure the Competition.
Our research reveals a weak, compromised competitive set leaving open multiple opportunities for Zipnosis to win in B2C.
Imagine the Experience.
Our recommendation: target consumers when and where they seek information to self-diagnose, build a strong visual brand to stand out from competitive clutter, deliver a frictionless customer intake experience, and adopt an easy-to-engage consumer-pricing model.
Pilot. Test. Iterate. Grow.
Infallible proposes a market test targeting four states with the greatest demand for Skin Health.